Regulation of snoRNAs in cancer: Close encounters with interferon

Journal of Interferon and Cytokine Research

Volumn 33, Issue 4, 2013, Pages 189-198

  Nallar, Shreeram C ^a   Kalvakolanu, Dhananjaya V ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CORE PROTEIN; INTERFERON; MICRORNA; RIBONUCLEOPROTEIN; RIBOSOME RNA; RNA 5.8S; RNA 5S; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; SMALL NUCLEOLAR RNA; SURVIVAL MOTOR NEURON PROTEIN;

ANEUPLOIDY; BIOGENESIS; CANCER GROWTH; CANCER INHIBITION; CELL VIABILITY; CHROMOSOME 12; CHROMOSOME BREAKAGE; COILED BODY; COLONY FORMATION; GENETIC SCREENING; GENOMIC INSTABILITY; GROWTH INHIBITION; HUMAN; LIVER CELL CARCINOMA; MATURATION; MITOCHONDRIAL PERMEABILITY; NEOPLASM; NONHUMAN; NUCLEOLUS; ONCOGENE; POINT MUTATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ASSEMBLY; PROTEIN METABOLISM; REVIEW; RIBOSOME SUBUNIT; SPLICEOSOME; SQUAMOUS CELL CARCINOMA; TELOMERE HOMEOSTASIS;

APOPTOSIS REGULATORY PROTEINS; CARRIER PROTEINS; HUMANS; INTERFERONS; NEOPLASMS; NUCLEOLUS ORGANIZER REGION; RNA, RIBOSOMAL; RNA, SMALL NUCLEOLAR;

EID: 84876120626     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2012.0106     Document Type: Review

References (101)

1. Anderson SJ, Lauritsen JP, Hartman MG, Foushee AM, Lefebvre JM, et al. 2007. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53- dependent checkpoint. Immunity 26:759-772.
2. Angell JE, Lindner DJ, Shapiro PS, Hofmann ER, Kalvakolanu DV. 2000. Identification of GRIM-19, a novel cell death-regulatory gene induced by the interferon-beta and retinoic acid combination, using a genetic approach. J Biol Chem 275: 33416-33426.
3. Angrisani A, Turano M, Paparo L, Di Mauro C, Furia M. 2011. A new human dyskerin isoform with cytoplasmic localization. Biochim Biophys Acta 1810:1361-1368.
4. Appaiah HN, Goswami CP, Mina LA, Badve S, Sledge GW, Jr., et al. 2011. Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients. Breast Cancer Res 13:R86.
5. Askarian-Amiri ME, Crawford J, French JD, Smart CE, Smith MA, et al. 2011. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA 17:878-891.
6. Balakin AG, Smith L, Fournier MJ. 1996. The RNA world of the nucleolus: two major families of small RNAs defined by different box elements with related functions. Cell 86:823- 834.
7. Belin S, Beghin A, Solano-Gonzalez E, Bezin L, Brunet-Manquat S, et al. 2009. Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. PLoS One 4:e7147.
8. Bellodi C, Kopmar N, Ruggero D. 2010a. Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J 29:1865- 1876.
9. Bellodi C, Krasnykh O, Haynes N, Theodoropoulou M, Peng G, et al. 2010b. Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res 70:6026-6035.
10. Bodi Z, Zhong S, Mehra S, Song J, Graham N, et al. 2012. Adenosine methylation in Arabidopsis mRNA is associated with the 3′ end and reduced levels cause developmental defects. Front Plant Sci 3:48.
11. Bojovic B, Crowe DL. 2011. Telomere dysfunction promotes metastasis in a TERC null mouse model of head and neck cancer. Mol Cancer Res 9:901-913.
12. Boulon S, Verheggen C, Jady BE, Girard C, Pescia C, et al. 2004. PHAX and CRM1 are required sequentially to transport U3 snoRNA to nucleoli. Mol Cell 16:777-787.
13. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. 1997. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3:1271-1274.
14. Bullinger L, Kronke J, Schon C, Radtke I, Urlbauer K, et al. 2010. Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis. Leukemia 24:438-449.
15. Castle JC, Armour CD, Lower M, Haynor D, Biery M, et al. 2010. Digital genome-wide ncRNA expression, including SnoRNAs, across 11 human tissues using polyA-neutral amplification. PLoS One 5:e11779.
16. Chaneton B, Gottlieb E. 2012. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer. Trends Biochem Sci 37:309-316.
17. Chen HH, Chang JG, Lu RM, Peng TY, Tarn WY. 2008. The RNA binding protein hnRNP Q modulates the utilization of exon 7 in the survival motor neuron 2 (SMN2) gene. Mol Cell Biol 28:6929-6938.
18. Clower CV, Chatterjee D, Wang Z, Cantley LC, Vander Heiden MG, et al. 2010. The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc Natl Acad Sci U S A 107:1894-1899.
19. Collins K, Mitchell Jr. 2002. Telomerase in the human organism. Oncogene 21:564-579.
20. Creagan RP, Tan YH, Chen S, Ruddle FH. 1975. Somatic cell genetic analysis of the interferon system. Fed Proc 34:2222-2226.
21. Decatur WA, Fournier MJ. 2002. rRNA modifications and ribosome function. Trends Biochem Sci 27:344-351.
22. Decatur WA, Fournier MJ. 2003. RNA-guided nucleotide modification of ribosomal and other RNAs. J Biol Chem 278: 695-698.
23. de los Santos T, Schweizer J, Rees CA, Francke U. 2000. Small evolutionarily conserved RNA, resembling C/D box small nucleolar RNA, is transcribed from PWCR1, a novel imprinted gene in the Prader-Willi deletion region, which Is highly expressed in brain. Am J Hum Genet 67:1067-1082.
24. Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon- Divon M, Ungar L, et al. 2012. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485:201-206.
25. Dong XY, Guo P, Boyd J, Sun X, Li Q, et al. 2009. Implication of snoRNA U50 in human breast cancer. J Genet Genomics 36:447-454.
26. Dong XY, Rodriguez C, Guo P, Sun X, Talbot JT, et al. 2008. SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet 17:1031-1042.
27. Donsante A, Miller DG, Li Y, Vogler C, Brunt EM, et al. 2007. AAV vector integration sites in mouse hepatocellular carcinoma. Science 317:477.
28. Dunn GP, Koebel CM, Schreiber RD. 2006. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6:836-848.
29. Eliceiri GL. 2006. The vertebrate E1/U17 small nucleolar ribonucleoprotein particle. J Cell Biochem 98:486-495.
30. Ender C, Krek A, Friedlander MR, Beitzinger M, Weinmann L, et al. 2008. A human snoRNA with microRNA-like functions. Mol Cell 32:519-528.
31. Enninga J, Levy DE, Blobel G, Fontoura BM. 2002. Role of nucleoporin induction in releasing an mRNA nuclear export block. Science 295:1523-1525.
32. Flomen R, Knight J, Sham P, Kerwin R, Makoff A. 2004. Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene. Nucleic Acids Res 32:2113-2122.
33. Fromont-Racine M, Senger B, Saveanu C, Fasiolo F. 2003. Ribosome assembly in eukaryotes. Gene 313:17-42.
34. Ge J, Rudnick DA, He J, Crimmins DL, Ladenson JH, et al. 2010. Dyskerin ablation in mouse liver inhibits rRNA processing and cell division. Mol Cell Biol 30:413-422.
35. Gee HE, Buffa FM, Camps C, Ramachandran A, Leek R, et al. 2011. The small-nucleolar RNAs commonly used for micro- RNA normalisation correlate with tumour pathology and prognosis. Br J Cancer 104:1168-1177.
36. Gewin L, Myers H, Kiyono T, Galloway DA. 2004. Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex. Genes Dev 18: 2269-2282.
37. Gordon FE, Nutt CL, Cheunsuchon P, Nakayama Y, Provencher KA, et al. 2010. Increased expression of angiogenic genes in the brains of mouse meg3-null embryos. Endocrinology 151: 2443-2452.
38. Grozdanov PN, Roy S, Kittur N, Meier UT. 2009. SHQ1 is required prior to NAF1 for assembly of H/ACA small nucleolar and telomerase RNPs. RNA 15:1188-1197.
39. Gu T, He H, Han Z, Zeng T, Huang Z, et al. 2012. Expression of macro non-coding RNAs Meg8 and Irm in mouse embryonic development. Acta Histochem 114:392-399.
40. Guo J, Hui DJ, Merrick WC, Sen GC. 2000. A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J 19:6891-6899.
41. He J, Navarrete S, Jasinski M, Vulliamy T, Dokal I, et al. 2002. Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice. Oncogene 21:7740-7744.
42. Hofmann ER, Boyanapalli M, Lindner DJ, Weihua X, Hassel BA, et al. 1998. Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid. Mol Cell Biol 18:6493-6504.
43. Hofmann ER, Nallar SC, Lin L, D'Cunha J, Lindner DJ, et al. 2010. Identification and characterization of GRIM-1, a celldeath- associated gene product. J Cell Sci 123:2781-2791.
44. Isaac C, Yang Y, Meier UT. 1998. Nopp140 functions as a molecular link between the nucleolus and the coiled bodies. J Cell Biol 142:319-329.
45. Jiang YH, Armstrong D, Albrecht U, Atkins CM, Noebels JL, et al. 1998. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21: 799-811.
46. Kalvakolanu DV. 2004. The GRIMs: a new interface between cell death regulation and interferon/retinoid induced growth suppression. Cytokine Growth Factor Rev 15:169- 194.
47. Kato L, Begum NA, Burroughs AM, Doi T, Kawai J, et al. 2012. Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes. Proc Natl Acad Sci U S A 109:2479-2484.
48. King TH, Decatur WA, Bertrand E, Maxwell ES, Fournier MJ. 2001. A well-connected and conserved nucleoplasmic helicase is required for production of box C/D and H/ACA snoRNAs and localization of snoRNP proteins. Mol Cell Biol 21:7731-7746.
49. Kirwan M, Dokal I. 2008. Dyskeratosis congenita: a genetic disorder of many faces. Clin Genet 73:103-112.
50. Kishore S, Khanna A, Zhang Z, Hui J, Balwierz PJ, et al. 2010. The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing. Hum Mol Genet 19:1153-1164.
51. Kishore S, Stamm S. 2006. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 311:230-232.
52. Kiss T, Fayet E, Jady BE, Richard P, Weber M. 2006. Biogenesis and intranuclear trafficking of human box C/D and H/ACA RNPs. Cold Spring Harb Symp Quant Biol 71:407-417.
53. Li H, Tai BC. 2006. RNASEL gene polymorphisms and the risk of prostate cancer: a meta-analysis. Clin Cancer Res 12: 5713-5719.
54. Liao J, Yu L, Mei Y, Guarnera M, Shen J, et al. 2010. Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer 9:198.
55. Marinus MG, Morris NR. 1973. Isolation of deoxyribonucleic acid methylase mutants of Escherichia coli K-12. J Bacteriol 114:1143-1150.
56. Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. 2005. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol 15:300-308.
57. Mei YP, Liao JP, Shen J, Yu L, Liu BL, et al. 2011. Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis. Oncogene 31:2794-2804.
58. Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE, et al. 2012. Comprehensive analysis of mRNA methylation reveals enrichment in 3′ UTRs and near stop codons. Cell 149:1635-1646.
59. Michel CI, Holley CL, Scruggs BS, Sidhu R, Brookheart RT, et al. 2011. Small nucleolar RNAs U32a, U33, and U35a are critical mediators of metabolic stress. Cell Metab 14:33-44.
60. Mishra RK, Eliceiri GL. 1997. Three small nucleolar RNAs that are involved in ribosomal RNA precursor processing. Proc Natl Acad Sci U S A 94:4972-4977.
61. Montanaro L, Calienni M, Bertoni S, Rocchi L, Sansone P, et al. 2010. Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res 70: 4767-4777.
62. Morimoto K, Lin S, Sakamoto K. 2007. The functions of RPS19 and their relationship to Diamond-Blackfan anemia: a review. Mol Genet Metab 90:358-362.
63. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. 2009. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28:195-208.
64. Mukhopadhyay R, Ray PS, Arif A, Brady AK, Kinter M, et al. 2008. DAPK-ZIPK-L13a axis constitutes a negative-feedback module regulating inflammatory gene expression. Mol Cell 32:371-382.
65. Nallar SC, Lin L, Srivastava V, Gade P, Hofmann ER, et al. 2011. GRIM-1, a novel growth suppressor, inhibits rRNA maturation by suppressing small nucleolar RNAs. PLoS One 6:e24082.
66. Nicholls RD, Knepper JL. 2001. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu Rev Genomics Hum Genet 2:153-175.
67. Noguchi T, Inoue H, Tanaka T. 1986. The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing. J Biol Chem 261:13807- 13812.
68. Ofengand J, Bakin A. 1997. Mapping to nucleotide resolution of pseudouridine residues in large subunit ribosomal RNAs from representative eukaryotes, prokaryotes, archaebacteria, mitochondria and chloroplasts. J Mol Biol 266:246-268.
69. Pelczar P, Filipowicz W. 1998. The host gene for intronic U17 small nucleolar RNAs in mammals has no protein-coding potential and is a member of the 5′-terminal oligopyrimidine gene family. Mol Cell Biol 18:4509-4518.
70. Pellizzoni L, Baccon J, Charroux B, Dreyfuss G. 2001. The survival of motor neurons (SMN) protein interacts with the snoRNP proteins fibrillarin and GAR1. Curr Biol 11:1079-1088.
71. Rakauskaite R, Dinman JD. 2011. Mutations of highly conserved bases in the peptidyltransferase center induce compensatory rearrangements in yeast ribosomes. RNA 17:855-864.
72. Richard P, Darzacq X, Bertrand E, Jady BE, Verheggen C, et al. 2003. A common sequence motif determines the Cajal bodyspecific localization of box H/ACA scaRNAs. EMBO J 22:4283-4293.
73. Roy NS, Nakano T, Keyoung HM, Windrem M, Rashbaum WK, et al. 2004. Telomerase immortalization of neuronally restricted progenitor cells derived from the human fetal spinal cord. Nat Biotechnol 22:297-305.
74. Ruddle FH, Creagan RP. 1975. Parasexual approaches to the genetics of man. Annu Rev Genet 9:407-486.
75. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, et al. 1999. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96:701-712.
76. Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, et al. 2003. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299:259-262.
77. Runte M, Varon R, Horn D, Horsthemke B, Buiting K. 2005. Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader-Willi syndrome. Hum Genet 116:228-230.
78. Sahoo T, del Gaudio D, German JR, Shinawi M, Peters SU, et al. 2008. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet 40:719-721.
79. Samuel CE. 1979. Mechanism of interferon action: phosphorylation of protein synthesis initiation factor eIF-2 in interferon-treated human cells by a ribosome-associated kinase processing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc Natl Acad Sci U S A 76:600-604.
80. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
81. Schippert R, Schaeffel F, Feldkaemper MP. 2008. Microarray analysis of retinal gene expression in chicks during imposed myopic defocus. Mol Vis 14:1589-1599.
82. Scott MS, Avolio F, Ono M, Lamond AI, Barton GJ. 2009. Human miRNA precursors with box H/ACA snoRNA features. PLoS Comput Biol 5:e1000507.
83. Silvera D, Formenti SC, Schneider RJ. 2010. Translational control in cancer. Nat Rev Cancer 10:254-266.
84. Song S, Pitot HC, Lambert PF. 1999. The human papillomavirus type 16 E6 gene alone is sufficient to induce carcinomas in transgenic animals. J Virol 73:5887-5893.
85. Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, et al. 2010. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465: 175-181.
86. Stefan M, Simmons RA, Bertera S, Trucco M, Esni F, et al. 2011. Global deficits in development, function, and gene expression in the endocrine pancreas in a deletion mouse model of Prader- Willi syndrome. Am J Physiol Endocrinol Metab 300: E909-E922.
87. Tanaka R, Satoh H, Moriyama M, Satoh K, Morishita Y, et al. 2000. Intronic U50 small-nucleolar-RNA (snoRNA) host gene of no protein-coding potential is mapped at the chromosome breakpoint t(3;6)(q27;q15) of human B-cell lymphoma. Genes Cells 5:277-287.
88. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, et al. 2010. Integrative genomic profiling of human prostate cancer. Cancer Cell 18:11-22.
89. Terns M, Terns R. 2006. Noncoding RNAs of the H/ACA family. Cold Spring Harb Symp Quant Biol 71:395-405.
90. Tu W, Xu X, Peng L, Zhong X, Zhang W, et al. 2010. DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke. Cell 140:222-234.
91. Tyc K, Steitz JA. 1989. U3, U8 and U13 comprise a new class of mammalian snRNPs localized in the cell nucleolus. EMBO J 8:3113-3119.
92. Vulliamy TJ, Dokal I. 2008. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex. Biochimie 90:122-130.
93. Wilson GG. 1991. Organization of restriction-modification systems. Nucleic Acids Res 19:2539-2566.
94. Wu G, Xiao M, Yang C, Yu YT. 2011. U2 snRNA is inducibly pseudouridylated at novel sites by Pus7p and snR81 RNP. EMBO J 30:79-89.
95. Wu H, Feigon J. 2007. H/ACA small nucleolar RNA pseudouridylation pockets bind substrate RNA to form three-way junctions that position the target U for modification. Proc Natl Acad Sci U S A 104:6655-6660.
96. Yang PK, Rotondo G, Porras T, Legrain P, Chanfreau G. 2002. The Shq1p.Naf1p complex is required for box H/ACA small nucleolar ribonucleoprotein particle biogenesis. J Biol Chem 277:45235-45242.
97. Zhang J, Harnpicharnchai P, Jakovljevic J, Tang L, Guo Y, et al. 2007. Assembly factors Rpf2 and Rrs1 recruit 5S rRNA and ribosomal proteins rpL5 and rpL11 into nascent ribosomes. Genes Dev 21:2580-2592.
98. Zhou A, Hassel BA, Silverman RH. 1993. Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72:753-765.
99. Zhou Y, Zhang X, Klibanski A. 2012. MEG3 noncoding RNA: a tumor suppressor. J Mol Endocrinol 48:R45-R53.
100. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, et al. 2007. Activation of p53 by MEG3 non-coding RNA. J Biol Chem 282:24731-24742.
101. Zhu PJ, Huang W, Kalikulov D, Yoo JW, Placzek AN, et al. 2011. Suppression of PKR promotes network excitability and enhanced cognition by interferon-gamma-mediated disinhibition. Cell 147:1384-1396.